Investment
Features
FeesSafety
Academy
More
Pluang+

Blueberries Medical raises C$1.1M in private placement to expand cannabis operations in Colombia

Company Fundamentals
29 Jul 2026
Accesswire
View Source
Bullish
Blueberries Medical raises C$1.1M in private placement to expand cannabis operations in Colombia

Blueberries Medical Corp., a licensed producer of cannabis derivatives in Colombia, announced a non-brokered private placement raising approximately C$1.1 million by selling 84.6 million common shares at C$0.013 each. The funds will be used to expand operations, support general corporate needs, and enhance working capital. The offering is expected to close around August 26, 2026, and is led by Terraflos Inc., a key investor controlled by Blueberries' CEO. This financing supports Blueberries' growth in health, wellness, and longevity sectors through scalable production of plant-based bioactives and cannabis products.

More News

THOR Industries misses Q4 EPS estimates but beats revenue expectations amid RV market challenges

THOR Industries misses Q4 EPS estimates but beats revenue expectations amid RV market challenges

THOR Industries reported Q4 earnings with an EPS of $0.78, missing analyst estimates and showing a 66.9% drop from last year. Despite this, the company beat revenue expectations with $2.31 billion, though revenue declined 8.4% year-over-year due to w...

Company Fundamentals
Bearish
52 minutes ago
Cracker Barrel earnings expected to drop sharply in Q3 2026, with EPS forecast at $0.17 and revenue down.

Cracker Barrel earnings expected to drop sharply in Q3 2026, with EPS forecast at $0.17 and revenue down.

Cracker Barrel Old Country Store is set to report its Q3 2026 earnings on September 23, with analysts predicting a significant decline. Earnings per share are expected to fall to $0.17 from $0.74 last year, and revenue is forecasted around $834.57 mi...

Company Fundamentals
Bearish
58 minutes ago
Abivax gains FDA nod for Obefazimod, backed by strong cash and positive analyst outlook.

Abivax gains FDA nod for Obefazimod, backed by strong cash and positive analyst outlook.

Abivax received positive pre-NDA feedback from the U.S. FDA for its drug Obefazimod, marking a key step in its development. Despite a recent price target cut by Wedbush to $118, analysts maintain a "Moderate Buy" consensus with an average target of $...

Market News
Bullish
1 hour ago
Netflix stock downgraded by HSBC and Wells Fargo over falling viewer engagement.

Netflix stock downgraded by HSBC and Wells Fargo over falling viewer engagement.

HSBC and Wells Fargo have downgraded Netflix stock due to declining subscriber engagement and an 8% drop in viewership time. Despite a recent 2.19% stock gain, Netflix shares have fallen over 40% in the past year amid strong competition and weaker or...

Market News
Bearish
1 hour ago
FormFactor director sells 2,100 shares, signaling insider stock movement

FormFactor director sells 2,100 shares, signaling insider stock movement

A director at FormFactor sold 2,100 shares, indicating a notable insider transaction. Such sales can reflect personal financial decisions or strategic portfolio adjustments by company insiders. Investors often watch these moves for potential signals ...

Market News
Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App